Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PaxVax has entered into a definitive agreement to be acquired by Emergent BioSolutions.
read more
Emergent BioSolutions will collaborate with Novavax to support bringing into the clinic Novavax’s novel experimental vaccine candidate to protect against coronavirus disease (COVID-19).
read more
Wednesday, March 04, 2020
Axiom Real-Time Metrics announced its engagement with Emergent BioSolutions.
read more
Emergent BioSolutions has announced that its Center for Innovation in Advanced Developmentand Manufacturing (CIADM) has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $21.9 million to ...
read more
Monday, September 24, 2018
ABEC announced the shipment of Emergent BioSolutions’ CSR dual purpose single-use systems for large scale 750L microbial fermentation and 500L mammalian cell culture.
read more
Monday, September 09, 2019
Emergent BioSolutions announced a contract award by the HHS over 10 years for the continued supply of ACAM2000® into the U.S. Strategic National Stockpile.
read more
Tuesday, September 19, 2017
Emergent BioSolutions has been awarded a contract valued at approximately $63 million by the BARDA to develop an antidote spray device for the treatment of known or suspected acute cyanide poisoning.
read more
Emergent BioSolutions has signed an indefinite-delivery, IDIQ contract with the Department of State to establish a long-term supply chain for medical countermeasures that address chemical warfare agents.
read more
Wednesday, April 04, 2018
Effective immediately, the company’s board of directors promoted Robert G. Kramer Sr. to the newly-created position of president and COO, and appointed Richard S. Lindahl as the company’s new executive vice president and CFO.
read more
Wednesday, December 03, 2025
Emerald Clinical Trials announced the appointment of Luke Gill, MSc, MBA, as Vice President, Global Head of Oncology, Medical & Scientific Affairs. This appointment underscores Emerald's continued investment in advancing oncology innovation and ...
read more
Wednesday, March 10, 2021
eMed and Cardinal Health announced a collaboration to distribute millions of at-home COVID-19 rapid tests to pharmacies across the continental United States, Puerto Rico and U.S. Virgin Islands.
read more
EMED announced the SCIg60 Infusion System has been granted expanded indications as the only Immune Globulin Subcutaneous mechanical pump infusion system cleared by the FDA.
read more
Sunday, September 18, 2016
EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt,Germany in the US and Canada, has announced the appointment of Craig Millian as Senior Vice President, Neurology and Immunology.
read more
Tuesday, October 24, 2017
EMD Serono announced the appointment of Robert Truckenmiller as Senior Vice President, Market Access & Customer Solutions.
read more
EMD Millipore and Singulex have entered into a definitive agreement under which EMD Millipore will control and manage the Singulex Life Science Research business.
read more